vimarsana.com

SOUTH SAN FRANCISCO (dpa-AFX) - Roche AG (RO), a Swiss multinational healthcare company, said on Monday that it plans to launch SARS-CoV-2 and Flu A/B Rapid Antigen Test for professional use in

Related Keywords

Switzerland ,Swiss , ,Drug Administration ,Sd Biosensor Inc ,Emergency Use Authorization ,Roche ,Launch ,Pest ,Its ,Etect ,Differentiate ,Between ,Covid ,Influenza ,Viruses ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.